Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
SLSLBTthis companySL Science Holding Ltd	$0.95	0×	0×	0×	0.28×	-129.4%	35.3%	-174.6%	-173.8%	-167.2%	-153.7%	0.0%	0.09×	0.28×	0×	3.05×	0.0%	—	—	1	C-
ACRSAclaris Therapeutics, Inc.	$4.18	-5.68×	3.58×	47.18×	-5.45×	-122.2%	73.3%	-975.9%	-829.6%	-63.0%	-57.7%	-12.8%	0.02×	0.28×	0×	5.28×	0.0%	2	-2.65	1	D+
TTRXTurn Therapeutics Inc.	$9.64	-17.13×	11.55×	0×	-15.65×	-98.2%	0.0%	0.0%	0.0%	-68.2%	-94.4%	-5.0%	0.02×	1.59×	0×	0.87×	0.0%	1	7.69	1	D+
Peer median	—	-11.4×	7.57×	23.59×	-10.55×	-110.2%	36.6%	-488.0%	-414.8%	-65.6%	-76.1%	-8.9%	0.02×	0.93×	0×	3.07×	0.0%	2	2.52	1	—